Mobile hybrid expansion Soterix Medical launched MxN-GO EEG, a wire-free HD-tES and EEG system, and partners with mBrainTrain to enable mobile hybrid stimulation/EEG studies. This indicates a strong opportunity to position portable neuromodulation and remote monitoring solutions to clinics and research sites pursuing mobile brain stimulation protocols.

Clinical reach growth With a focus on safe, effective, and user-friendly neuromodulation technology and recent product launches, there is potential to upsell to clinics and hospital-based neurophysiology departments seeking advanced stimulation and monitoring capabilities for non-invasive brain interventions.

Strategic partnerships The collaboration with mBrainTrain for mobile EEG suggests a channel strategy that can be leveraged to co-sell integrated hardware and software solutions to research centers, universities, and contract research organizations conducting remote or mixed-location studies.

Innovation signaling Recent press indicates rapid product introductions and un-tethered design innovations. This positions Soterix as a forward-thinking vendor to target early adopters in academic and clinical research areas looking to upgrade to wireless EEG and HD-tES workflows.

Funding traction Past NIMH fast-track funding reinforces credibility and potential for grant-backed collaborations. Target grant-dependent researchers and facilities pursuing neuromodulation projects, offering bundled hardware, software, and service packages aligned with grant requirements.